3D 이미징 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 전개별, 조직별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

3D Imaging Market Size, Share & Trends Analysis Report By Component (Software, Hardware, Services), By Deployment (On-premise, Cloud), By Organization (Large Enterprises, SMEs), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 4,950 ￦ 6,859,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950 ￦ 8,245,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 7,950 ￦ 11,017,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

3D 이미징 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 3D 이미징 시장 규모는 2030년까지 1,159억 8,000만 달러에 달할 것으로 예상되며, 2025년부터 2030년까지 18.5%의 CAGR을 기록할 것으로 예상됩니다.

미디어 및 엔터테인먼트 분야의 3D 이미징 기술은 3D 비디오 게임과 극장용 영화에 대한 수요가 해마다 급증하고 있으며, 이는 시장의 주요 촉진요인 중 하나입니다.

COVID-19는 3D 이미징 시장에 큰 영향을 미쳤습니다. 전염병으로 인해 봉쇄령이 내려졌고, 여러 산업에서 수출입과 제조가 일시적으로 금지되었습니다. 제조 공장의 폐쇄로 인해 폐쇄된 지역의 사업과 수익이 크게 손실되었습니다. 세계 공급망의 혼란은 세계 시장에서의 제품 판매, 납기 및 제조에 부정적인 영향을 미쳤으며, 3D 영상 매출은 눈에 띄게 감소했습니다.

M&A, 계약, 확장은 지난 몇 년 동안 기업들이 채택한 주요 전략입니다. 예를 들어, 2021년 8월 FARO Technologies는 스웨덴에 본사를 둔 3D 디지털 트윈 솔루션 기술 업체인 ATS AB의 인수를 발표했습니다. 이 계약에는 FARO Webshare Cloud 시스템에 ATS의 특허받은 추적 가능한 3D 시스템과 소프트웨어를 통합하여 정확하고 반복 가능한 3D 스캐닝을 가능하게 하는 ATS의 특허받은 추적 가능한 3D 시스템 및 소프트웨어가 포함됩니다.

3D 이미징 시장 보고서 하이라이트

• 하드웨어 분야는 2024년 48.0% 이상의 가장 큰 매출 점유율을 차지했으며, 예측 기간 동안에도 시장을 지배할 것으로 예상됩니다. 이는 헬스케어 분야에서 엑스레이 장비, 초음파 시스템, CT, MRI 등 3D 이미징 장비에 대한 수요가 증가하고 있기 때문입니다.
• 온프레미스 부문은 2024년 77.0% 이상의 가장 큰 매출 점유율을 차지했으며, 예측 기간 동안 시장 지위를 유지할 것으로 예상됩니다. 이는 일회성 라이선스 구매, 언제든지 액세스할 수 있는 내부 네트워크, 로컬에 데이터가 저장되기 때문에 높은 보안성 때문인 것으로 분석됩니다.
• 대기업 부문은 2024년 57.0% 이상의 가장 큰 매출 점유율을 차지했으며, 예측 기간 동안 계속해서 시장을 지배할 것으로 예상됩니다. 이는 개선된 제품을 생산하고 더 나은 고객 경험을 제공하기 위해 대기업에서 3D 이미징 하드웨어 및 솔루션의 사용이 증가하고 있기 때문입니다.
• 헬스케어 및 생명과학 분야는 2024년 53.0% 이상의 가장 큰 매출 점유율을 차지했으며, 예측 기간 동안 시장을 지배할 것으로 예상됩니다. 이는 헬스케어 분야에서 체내 질병을 판단하고 진단하기 위한 3D 의료 영상 기술의 채택이 증가하고 있으며, 이에 대한 수요가 증가하고 있기 때문으로 분석됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 3D 이미징 변수, 동향, 범위

• 시장 소개/계통 전망
• 업계 밸류체인 분석
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 업계 기회
• 3D 이미지 분석 툴
  • Porters 분석
  • PESTEL 분석

제4장 3D 이미징 시장 : 구성요소 추정·동향 분석

• 부문 대시보드
• 3D 이미징 : 컴포넌트 변동 분석, 2024년 및 2030년
• 소프트웨어
• 하드웨어
• 컴포넌트

제5장 3D 이미징 시장 : 전개 추정·동향 분석

• 부문 대시보드
• 3D 이미징 : 전개 변동 분석, 2024년과 2030년
• 온프레미스
• 클라우드

제6장 3D 이미징 시장 : 조직 추정·동향 분석

• 부문 대시보드
• 3D 이미징 : 조직 변동 분석, 2024년과 2030년
• 대기업
• 중소기업

제7장 3D 이미징 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 3D 이미징 : 최종 용도 변동 분석, 2024년 및 2030년
• 자동차·수송
• 제조업
• 헬스케어와 생명과학
• 아키텍처와 건설
• 미디어와 엔터테인먼트
• 보안과 감시
• 기타

제8장 3D 이미징 시장 : 지역 추정·동향 분석

• 3D 이미징 점유율, 지역별, 2024년 및 2030년
• 북미
  • 구성요소별, 2017-2030년
  • 전개별, 2017-2030년
  • 조직별, 2017-2030년
  • 최종 용도별, 2017-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 구성요소별, 2017-2030년
  • 전개별, 2017-2030년
  • 조직별, 2017-2030년
  • 최종 용도별, 2017-2030년
  • 영국
  • 독일
  • 프랑스
• 아시아태평양
  • 구성요소별, 2017-2030년
  • 전개별, 2017-2030년
  • 최종 용도별, 2017-2030년
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
• 라틴아메리카
  • 구성요소별, 2017-2030년
  • 전개별, 2017-2030년
  • 조직별, 2017-2030년
  • 최종 용도별, 2017-2030년
  • 브라질
• 중동 및 아프리카
  • 구성요소별, 2017-2030년
  • 전개별, 2017-2030년
  • 조직별, 2017-2030년
  • 최종 용도별, 2017-2030년
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제9장 경쟁 상황

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 분류
• 기업의 시장 점유율 분석
• 기업 히트맵 분석
• 전략 매핑
  • 확대
  • 인수합병
  • 파트너십과 협업
  • 신제품 발매
  • 연구개발
• 기업 개요
  • Ajile Light Industries
  • Alphatec Holdings, Inc.
  • eCential Robotics
  • FARO
  • GE HealthCare
  • Intrasense
  • Koninklijke Philips NV
  • Olympus America
  • Planmeca Oy
  • Siemens Healthineers AG
  • TOMTEC Imaging Systems GmbH.

ksm

영문 목차

영문목차

3D Imaging Market Growth & Trends:

The global 3D imaging market size is expected to reach USD 115.98 billion by 2030, registering to grow at a CAGR of 18.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The 3D imaging technology in the media and entertainment sector has been gaining momentum as the demand for 3D video games and theatrical films have risen tremendously over the years, acting as one of the key drivers in the market.

The COVID-19 pandemic significantly impacted the 3D imaging market. Lockdowns were implemented due to the pandemic that led to a temporary prohibition on import and export and manufacturing across multiple industries. The closure of manufacturing plants resulted in a significant loss of business and revenue for the regions under lockdown. The disruption in global supply chains negatively impacted the sales of products, delivery schedules, and manufacturing in the global market, which led to a notable drop in the sales of 3D imaging.

Mergers & acquisitions, agreements, and expansions are the key strategies adopted by the companies over the past years. For instance, in August 2021, FARO Technologies announced the acquisition of ATS AB, a Swedish-based company in 3D digital twin solution technology. The agreement will include the integration of ATS patented Traceable 3D system and software, which allows highly precise and reproducible 3D scans into the FARO Webshare Cloud system.

3D Imaging Market Report Highlights:

• The hardware segment accounted for the largest revenue share of over 48.0% in 2024 and is expected to continue to dominate the market over the forecast period. This can be attributed to the increasing demand for 3D imaging devices such as X-ray devices, ultrasound systems, CT, and MRI in healthcare deployment.
• The on-premise segment accounted for the largest revenue share of over 77.0% in 2024 and is expected to retain its position in the market over the forecast period. This can be attributed to a one-time upfront license purchase, an internal network that can be accessed anytime, and high security as data is stored locally.
• The large enterprise segment accounted for the largest revenue share of over 57.0% in 2024 and is expected to continue to dominate the market over the forecast period. This can be attributed to the increasing use of 3D imaging hardware and solutions in large enterprises to manufacture improved products and give a better customer experience
• The healthcare and life sciences segment accounted for the largest revenue share of over 53.0% in 2024 and is expected to continue to dominate the market over the forecast period. This can be attributed to the increasing adoption and growing need for 3D medical imaging technology in healthcare deployment to determine and diagnose the disease in the body.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Methodology segmentation & scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. 3D Imaging Variables, Trends & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
  • 3.3.3. Industry Opportunities
• 3.4. 3D Imaging Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. 3D Imaging Market: Component Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. 3D Imaging: Component Movement Analysis, 2024 & 2030 (USD Billion)
• 4.3. Software
  • 4.3.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 4.4. Hardware
  • 4.4.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 4.5. Components
  • 4.5.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 5. 3D Imaging Market: Deployment Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. 3D Imaging: Deployment Movement Analysis, 2024 & 2030 (USD Billion)
• 5.3. On-premise
  • 5.3.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 5.4. Cloud
  • 5.4.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 6. 3D Imaging Market: Organization Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. 3D Imaging: Organization Movement Analysis, 2024 & 2030 (USD Billion)
• 6.3. Large Enterprises
  • 6.3.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 6.4. Small and Medium-sized Enterprises
  • 6.4.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 7. 3D Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. 3D Imaging: End Use Movement Analysis, 2024 & 2030 (USD Billion)
• 7.3. Automotive and Transportation
  • 7.3.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.4. Manufacturing
  • 7.4.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.5. Healthcare and Life Sciences
  • 7.5.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.6. Architecture and Construction
  • 7.6.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.7. Media and Entertainment
  • 7.7.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.8. Security & Surveillance
  • 7.8.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)
• 7.9. Others
  • 7.9.1. Market Size Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 8. 3D Imaging Market: Regional Estimates & Trend Analysis

• 8.1. 3D Imaging Share, By Region, 2024 & 2030 (USD Billion)
• 8.2. North America
  • 8.2.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
  • 8.2.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.6. U.S.
    • 8.2.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.2.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.7. Canada
    • 8.2.7.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.2.7.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.7.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.7.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.7.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.2.8. Mexico
    • 8.2.8.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.2.8.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.8.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.8.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.2.8.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
• 8.3. Europe
  • 8.3.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
  • 8.3.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.6. U.K.
    • 8.3.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.3.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.7. Germany
    • 8.3.7.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.3.7.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.7.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.7.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.7.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.3.8. France
    • 8.3.8.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.3.8.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.8.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.8.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.3.8.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
• 8.4. Asia Pacific
  • 8.4.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
  • 8.4.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.3.1. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.4. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.5. China
    • 8.4.5.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.4.5.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.5.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.5.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.5.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.6. India
    • 8.4.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.4.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.7. Japan
    • 8.4.7.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.4.7.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.7.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.7.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.7.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.8. Australia
    • 8.4.8.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.4.8.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.8.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.8.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.8.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.4.9. South Korea
    • 8.4.9.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.4.9.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.9.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.9.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.4.9.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
• 8.5. Latin America
  • 8.5.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
  • 8.5.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
  • 8.5.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
  • 8.5.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
  • 8.5.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.5.6. Brazil
    • 8.5.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.5.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.5.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.5.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.5.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
• 8.6. Middle East & Africa
  • 8.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
  • 8.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.6. Saudi Arabia
    • 8.6.6.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.6.6.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.6.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.6.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.6.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.7. UAE
    • 8.6.7.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.6.7.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.7.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.7.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.7.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)
  • 8.6.8. South Africa
    • 8.6.8.1. Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 8.6.8.2. Market estimates and forecast by component, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.8.3. Market estimates and forecast by deployment, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.8.4. Market estimates and forecast by organization, 2017 - 2030 (Revenue, USD Billion)
    • 8.6.8.5. Market estimates and forecast by end use, 2017 - 2030 (Revenue, USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis
• 9.4. Company Heat Map Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Mergers & Acquisition
  • 9.5.3. Partnerships & Collaborations
  • 9.5.4. New Product Launches
  • 9.5.5. Research And Development
• 9.6. Company Profiles
  • 9.6.1. Ajile Light Industries
    • 9.6.1.1. Participant's Overview
    • 9.6.1.2. Financial Performance
    • 9.6.1.3. Product Benchmarking
    • 9.6.1.4. Recent Developments
  • 9.6.2. Alphatec Holdings, Inc.
    • 9.6.2.1. Participant's Overview
    • 9.6.2.2. Financial Performance
    • 9.6.2.3. Product Benchmarking
    • 9.6.2.4. Recent Developments
  • 9.6.3. eCential Robotics
    • 9.6.3.1. Participant's Overview
    • 9.6.3.2. Financial Performance
    • 9.6.3.3. Product Benchmarking
    • 9.6.3.4. Recent Developments
  • 9.6.4. FARO
    • 9.6.4.1. Participant's Overview
    • 9.6.4.2. Financial Performance
    • 9.6.4.3. Product Benchmarking
    • 9.6.4.4. Recent Developments
  • 9.6.5. GE HealthCare
    • 9.6.5.1. Participant's Overview
    • 9.6.5.2. Financial Performance
    • 9.6.5.3. Product Benchmarking
    • 9.6.5.4. Recent Developments
  • 9.6.6. Intrasense
    • 9.6.6.1. Participant's Overview
    • 9.6.6.2. Financial Performance
    • 9.6.6.3. Product Benchmarking
    • 9.6.6.4. Recent Developments
  • 9.6.7. Koninklijke Philips N.V.
    • 9.6.7.1. Participant's Overview
    • 9.6.7.2. Financial Performance
    • 9.6.7.3. Product Benchmarking
    • 9.6.7.4. Recent Developments
  • 9.6.8. Olympus America
    • 9.6.8.1. Participant's Overview
    • 9.6.8.2. Financial Performance
    • 9.6.8.3. Product Benchmarking
    • 9.6.8.4. Recent Developments
  • 9.6.9. Planmeca Oy
    • 9.6.9.1. Participant's Overview
    • 9.6.9.2. Financial Performance
    • 9.6.9.3. Product Benchmarking
    • 9.6.9.4. Recent Developments
  • 9.6.10. Siemens Healthineers AG
    • 9.6.10.1. Participant's Overview
    • 9.6.10.2. Financial Performance
    • 9.6.10.3. Product Benchmarking
    • 9.6.10.4. Recent Developments
  • 9.6.11. TOMTEC Imaging Systems GmbH.
    • 9.6.11.1. Participant's Overview
    • 9.6.11.2. Financial Performance
    • 9.6.11.3. Product Benchmarking
    • 9.6.11.4. Recent Developments

관련자료